Celling Biosciences

Celling Biosciences is a transformative leader innovating cellular therapy by integrating excellence in research, medical education, advocacy, and product development. Celling Biosciences is dedicated to the scientific understanding and therapeutic application of autologous cell therapy. Technologies developed by Celling Biosciences collect, process and deliver autologous cells to the patient at the point of care. The use of the patient’s own cells to promote healing provides a way of accelerating the body’s natural healing process. Celling Biosciences is a biotech company focused on the science, research and development of autologous cellular therapy. The ART PLUS Family of products is the only integrated ultra-filtration system on the market that allows for the processing of bone marrow, peripheral blood and growth factors at the point of care. The scientists and engineers behind Celling Biosciences have committed themselves to developing devices, techniques and clinical processes that optimize consistent, reliable, and reproducible cell therapy solutions. The product uses Celling Bioscience’s patented collection window and dial mechanism allowing precision control to achieve a high yield of platelets in a PRP volume that can be customized to the physician’s clinical requirements.